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Background: Mycobacterium tuberculosis is a pathogenic prokaryote adapted to survive in hostile environments.
In this organism and other Gram-positive actinobacteria, the metabolic pathways of glycogen and trehalose
are interconnected.
Results: In thisworkwe show theproduction, puriﬁcation and characterization of recombinant enzymes involved
in the partitioning of glucose-1-phosphate between glycogen and trehalose in M. tuberculosis H37Rv, namely:
ADP-glucose pyrophosphorylase, glycogen synthase, UDP-glucose pyrophosphorylase and trehalose-6-
phosphate synthase. The substrate speciﬁcity, kinetic parameters and allosteric regulation of each enzyme
were determined. ADP-glucose pyrophosphorylase was highly speciﬁc for ADP-glucose while trehalose-6-
phosphate synthase used not only ADP-glucose but also UDP-glucose, albeit to a lesser extent. ADP-glucose
pyrophosphorylase was allosterically activated primarily by phosphoenolpyruvate and glucose-6-phosphate,
while the activity of trehalose-6-phosphate synthase was increased up to 2-fold by fructose-6-phosphate.
None of the other two enzymes tested exhibited allosteric regulation.
Conclusions: Results give information about how the glucose-1-phosphate/ADP-glucose node is controlled after
kinetic and regulatory properties of key enzymes for mycobacteria metabolism.
General signiﬁcance: This work increases our understanding of oligo and polysaccharides metabolism in
M. tuberculosis and reinforces the importance of the interconnection between glycogen and trehalose biosynthe-
sis in this human pathogen.© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mycobacterium tuberculosis (Mtb) is the causative agent of tubercu-
losis (TB) in humans, which is one of the most serious pathogenic
prokaryotes and one of the leading causes of mortality due to a single
infectious agent [1]. Mtb is very successful as a pathogen that has
adapted itself to survive hostile environments [2]. Many of its metabolic
processes have not yet been fully described, and even pathways com-
mon to other organisms frequently exhibit distinctive characteristics
inMtb [3,4], which illustrates ametabolic plasticity that helps the organ-
ism to adapt and/or survive in the different microenvironments it isogía Molecular. Instituto de
ta Fe, Argentina. Fax: +54 342
.
. This is an open access article underchallenged with [4–9]. These particularities in the growth and survival
of Mtb under nutritionally restrictive conditions (for example in
the phagosome) represent attractive targets for new anti-tuberculosis
therapies to cope with latent infection of the bacterium [5].
Oligo and polysaccharides are relevant molecules in biology in
general, as they are involved in the storage of carbon and energy
reserves as well as in establishing cellular structures [10]. Glycogen is
a polysaccharide composed of glucose in anα-1,4-linked linear arrange-
ment with α-1,6-branches that serves as a storage molecule in many
organisms, including eukaryotes and prokaryotes [11,12]. Although
the particular physiological role of glycogen in bacteria has not been
clearly established, it was suggested that its accumulation could give
advantages during starvation periods, providing a stored source of
energy and carbon surplus [11]. In addition to glycogen, other two poly-
saccharides in Mtb are worth mentioning because of their important
physiological roles [13]. One is the extracellular α-glucan, a glycogen-
like polymer that is a major component of the capsule that surroundsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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the immune response of the host [14]. The second is methyl glucose
lipopolysaccharide (MGLP), an intracellular polymer taking part in
modulating the elongation of fatty acids [15–17]. On the other hand,
trehalose (Tre) is also a key carbohydrate in actinobacteria, and its syn-
thesis inmycobacteria was found to be critical because the disaccharide
acts as an energy reserve compound and also has structural relevance
[18]. Tre is found esteriﬁedwith different fatty acyl groups in themyco-
bacterial cell envelope, forming acyltrehaloses [18,19]. For example, Tre
esteriﬁed at positions 6 and 6′ by mycolates constitutes the compound
known as cord factor, which is a determinant for virulence and survival
of Mtb in host cells [20]. The synthesis of cord factor has therefore
attracted a lot of attention in the development of new anti-TB therapies.
Partitioning of Glc-1P into different metabolic pathways occurs at
the point of incorporation of the glycosidic moiety into nucleoside-
diphospho-Glc (NDP-Glc) by speciﬁc pyrophosphorylases. Subsequently,
different glycosyl transferases lead themonosaccharide to themultiface-
ted routes of carbohydrate anabolism. For the production of storage
and structural polysaccharides in bacteria, the synthesis of ADP-Glc and
UDP-Glc is most relevant. UDP-Glc is synthesized in a reaction catalyzed
by UDP-Glc PPase (EC 2.7.7.9), an enzyme ubiquitously distributed in
organisms with a critical role in carbohydrates metabolism [21]. Many
important nucleotide sugars such as UDP-xylose, UDP-glucuronic acid
and UDP-galactose derive from UDP-Glc [22]. Some of these activated
sugars are used to build the glycosidic structure of the bacterial cell
wall and capsule or more complex oligo and polysaccharides [22,23].
UDP-Glc PPases from prokaryotes are not known to be allosterically
regulated [24], sharing less than 10% identitywith their eukaryotic coun-
terparts [21].
Glycogen synthesis in prokaryotes involves the elongation of an
α-1,4-glycosidic chain by glycogen synthase (EC: 2.4.1.21; GSase),
using ADP-glucose (ADP-Glc) as the glucosyl donor [11,12]. In Gram-
negative bacteria and cyanobacteria, a key regulatory step in this
metabolic route occurs at the level of ADP-Glc synthesis, in the reaction
catalyzed by allosteric ADP-Glc pyrophosphorylase (EC: 2.7.7.27; ADP-
Glc PPase) [11,25]. Much less is known concerning what happens in
Gram-positive bacteria, with recent reports showing important differ-
ences in allosteric regulation [26,27]. ADP-Glc PPase and GSase are
respectively coded by glgC and glgA which, with the addition of glgB
(the gene coding for branching enzyme), establish the classical GlgCA
pathway for bacterial glycogen synthesis [28].
In Mtb, the OtsAB pathway is essential in synthesizing Tre with
the use of NDP-Glc by Tre-6P synthase [29–31]. It has been recently
demonstrated [28,32] that in mycobacteria Tre constitutes a glycogen
precursor via a novel pathway (GlgE route), where the dissacharide is
converted to maltose and activated to maltose-1P, the latter being
transferred to anα-polyglucanmolecule. The GlgE pathway thus estab-
lishes a metabolic link between Tre and polysaccharides, whose coordi-
nated function and regulation are of relevance for the physiology of the
microorganism. GlgE is known to be negatively regulated by phosphor-
ylation [33] and has been genetically validated as a potential drug target
[34]. To what extent each of the GlgE and GlgCA pathways contribute to
cytosolic glycogen and capsular α-glucan is not yet known.
In general, efforts devoted to the characterization of enzymes related
to glycogen metabolism in Gram-positive bacteria are scarce [11].
Recently, our group approached this issue in Streptomyces coelicolor
[27] and Streptococcus mutans [26], where Glc-1P partitioning was
understood to be controlled by the allosteric regulation of ADP-Glc
PPase. In this work we extend this analysis to the metabolism in Mtb,
studying the enzymes directing monosaccharides to glycogen and Tre
synthesis. We report the molecular cloning and expression of Mtb
genes coding for ADP-Glc PPase, UDP-Glc PPase, GSase and Tre-6P
Sase and characterization of their recombinant products. Kinetic param-
eters were determined and ADP-Glc PPase regulatory properties were
analyzed in detail. Biochemical data are discussed in the context of the
metabolism of Tre, glycogen and α-glucan synthesis in mycobacteria,revealing how such a central metabolic node in the production of
NDP-Glc is regulated in an important human pathogen.
2. Materials and methods
2.1. Chemicals
Restriction enzymes were purchased from Promega. All protein
standards, antibiotics, isopropyl-β-thiogalactoside (IPTG) and oligonu-
cleotides were obtained from Sigma-Aldrich (Saint Louis, MO, USA).
All the other reagents were of the highest quality available.
2.2. Bacteria and plasmids
Escherichia coli Top 10 F′ cells (Invitrogen) and the pGEM®-T Easy
vector (Promega) were used for cloning procedures. Expression
of otsA was performed in E. coli BL21 (DE3) using pRSETA vector
(Invitrogen). On the other hand, glgA, glgC and galU genes were
expressed in M. smegmatis mc2155 using the shuttle vector pMIP12
(from Pasteur Institute, Paris, France). Previously, this plasmid was
used to obtain a number of proteins fromdifferent organisms for immu-
nological purposes [35]. DNA manipulations, E. coli and M. smegmatis
cultures as well as transformations were performed according to
standard protocols [36,37].
2.3. Gene ampliﬁcation
Sequences encoding GSase (Rv1212c; glgA), ADP-Glc PPase (Rv1213;
glgC), UDP-Glc PPase (Rv0993; galU) and Tre-6P Sase (Rv3490; otsA)
from Mtb H37Rv were ampliﬁed by PCR using genomic DNA as the
template. Genomic DNA was kindly provided by Drs. Marisa Romano
and Fabiana Bigi, from INTA Castelar (Argentina). Primers are listed in
Supplemental Table I and were designed for each gene using available
genomic information [38,39] in the GenBank database (http://www.
ncbi.nlm.nih.gov/Genbank/index.html). PCR reaction mixtures (50 μl)
contained 100 ng of genomic DNA, 2 pg of each primer; 0.2 mM of
each dNTP; 2.5 mMMg2+, 5% (v/v) DMSO and 1 U Pfu DNA polymerase
(Fermentas). Standard conditions of PCRwere used for 30 cycles: dena-
turation at 94 °C for 1min; annealing at 74 °C for glgC, 71 °C for glgA and
70 °C for galU and otsA, for 30 s, and extension at 72 °C for 3min, with a
ﬁnal extension of 10min at 72 °C. PCR reaction mixtures were resolved
in 1% (w/v) agarose gels and PCR products were puriﬁed by means
of Wizard SV gel & PCR Clean Up kits (Promega). The ampliﬁed genes
[previously treated with Taq polymerase (Fermentas) and dATP] were
cloned into the T-tailed plasmid pGEM-TEasy.
2.4. Cloning procedures
Gene identities were conﬁrmed by DNA sequencing (Macrogen,
Korea). Afterwards, pGEM-TEasy plasmids harboring glgC or glgA coding
sequenceswere digestedwithKpnI and PstI and the released geneswere
cloned into pMIP12 to obtain the expression vectors pMIP12/glgC and
pMIP12/glgA. Similarly, pMIP12/galU was constructed inserting the
gene in the pMIP12 BamHI and PstI sites. Also, pGEM-TEasy/otsA
plasmid was treated with BamHI and HindIII restriction enzymes and
subcloned to obtain the pRSET/otsA expression vector. In the mycobac-
terial expression system employed, the recombinant proteinswere pro-
ducedwith a C-termHis-tag; whereas the Tre-6P Sase was expressed in
E. coli as a N-terminal His-tagged protein following a strategy similar to
that previously reported with slight modiﬁcations [40].
2.5. Production of ADP-Glc PPase, GSase and UDP-Glc PPase in
M. smegmatis mc2155
Competent M. smegmatis mc2155 cells were transformed with
pMIP12/glgA, pMIP12/glgC or pMIP12/galU according to established
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weremixedwith 200 ng of plasmidic DNA in a 2mmcuvette (HYBAID).
Electroporation was performed in a Thermo CelljecT Duo (HYBAID; set
at R = 335Ω, V = 2.5 kV and Φ = 15 μF). Cells were harvested in
1ml of LB-0.05 % Tween 80 and incubated for 3 h at 37 °Cwithout shak-
ing. Positive transformants were selected by plating M. smegmatis on
LB-Tween-agar containing 50 μg/ml of kanamycin. Expression in
M. smegmatiswas performed in LB-low salt (5 g/l of NaCl) medium sup-
plemented with 0.05% Tween 80 and 50 μg/ml of kanamycin. First, a
10 ml “starter culture”was grown for 24 h and used to inoculate 1 l of
the same medium. Expression cultures were incubated in an orbital
shaker at 200 rpm and grown for 96 h at 37 °C. Cells were harvested
by centrifugation at 5000 ×g for 10 min and stored at −20 °C until
processing.
2.6. Production of Tre-6P Sase in E. coli
Competent E. coli BL21 (DE3) cells were transformedwith pRSET/otsA
plasmid. Protein productionwas carried out using 2 l of LB supplemented
with 100 μg/ml ampicillin. Cells were grown at 37 °C and 250 rpm until
OD600 reached ~0.6 and induced for 16 h at 20 °C with 0.2 mM IPTG.
Cells were harvested by centrifugation at 5000 ×g for 10 min and stored
at−20 °C until use.
2.7. Puriﬁcation of recombinant proteins
Puriﬁcation procedures were carried out at 4 °C. Cells for each
expressing culture were harvested by centrifugation at 5000 ×g for
10 min, resuspended in Buffer A [20 mM Tris–HCl, pH 8.0, 400 mM
NaCl and 10mM imidazole] and disrupted by sonication on ice (5 pulses
of 30 s with 60 s intervals). The suspension was centrifuged twice at
10,000 ×g for 10 min and the supernatant (crude extract) was loaded
on a 1 ml HisTrap column (GE Healthcare) previously equilibrated
with Buffer A. The recombinant proteinwas elutedwith a linear gradient
from 10 to 300 mM imidazole in Buffer A (50 volumes), and fractions
containing the highest activity were pooled and concentrated to 2 ml.
Active ADP-Glc PPase and UDP-Glc PPase fractions were dialyzed
against Buffer B [50 mM MOPS pH, 8.0, 0.1 mM EDTA, 5 mM MgCl2,
5% (w/v) sucrose and 10% (v/v) glycerol]. GSase was dialyzed against
buffer containing triethanolamine-HCl 20 mM, pH 8.0, and 20% (v/v)
glycerol and Tre-6P Sase was dialyzed against a buffer containing
20 mM Tris–HCl, pH 8.0, and 10% (v/v) glycerol. In these conditions
the enzymes were stored at−80 °C until use, remaining fully actives
for at least 3 months.
2.8. Protein methods
Protein concentration was determined by the modiﬁed Bradford
assay [42] using BSA as a standard. Recombinant proteins and puriﬁ-
cation fractions were deﬁned by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) according to [43]. Gels were
loaded with 5 to 50 μg of protein per well and stained with
Coomassie-Brilliant Blue. Western blotting was performed using
standard techniques [37]. Proteins in the gel were blotted onto
PVDF membranes using a Mini-PROTEAN II (Bio-Rad) apparatus.
The membrane was blocked 2 h at room temperature and subse-
quently incubated overnight with primary antibody at 4 °C. Then,
membranes were incubated with rabbit anti-IgG conjugated to
peroxidase (Sigma) during 1 h at 25 °C. Detection was carried out
with 3,3-diaminobenzidine and hydrogen peroxide (Sigma) in
50 mM Tris–HCl, pH 8.0, and 150 mM NaCl.
Antibodies raised against Mtb ADP-Glc PPase or Xhantomonas
campestris UDP-Glc PPase [44] were produced in our lab according to
established methods [45] and used as primary antibodies. They were
puriﬁed from rabbit sera by consecutive precipitation steps with
ammonium sulfate 50% and 33% (twice) saturated solutions. Afterthat, antibodies were resuspended in TBS buffer (Tris–HCl pH 8.0, and
NaCl 150 mM) and desalted using an ultraﬁltration device with a
30 kDa cut-off (Amicom).
2.9. Enzyme activity assays
ADP-Glc PPase and UDP-Glc PPase activities were determined at
37 °C in both NDP-Glc pyrophosphorolysis (assay A) and synthesis
(assay B) directions.
Assay A. Pyrophosphorolysis of ADP-Glc or UDP-Glc was followed
by the formation of [32P]ATP or [32P]UTP, respectively, from [32P]PPi,
as previously described [46]. Reaction mixtures contained 50 mM
MOPS buffer, pH 8.0, 5 mM MgCl2, either 2 mM ADP-Glc or 1 mM
UDP-Glc (depending of the enzyme analyzed), 1 mM [32P]PPi
(3000 cpm/nmol), 10 mM NaF, 0.2 mg/ml BSA and enzyme in a ﬁnal
volume of 150 μl. Reactions were started with 32PPi addition and after
10 min of incubation at 37 °C were stopped with 1 ml of cold 10% (v/v)
trichloroacetic acid.
Assay B. Synthesis of ADP-Glc or UDP-Glc was assayed by following
the formation of Pi (after hydrolysis of PPi by inorganic pyrophosphatase)
with the highly sensitive colorimetric method previously described [47].
The reaction mixture contained 50 mM MOPS, pH 8.0, 5 mM MgCl2,
either 2 mM ATP or 1 mM UTP (depending of the enzyme analyzed),
0.2 mg/ml BSA, 0.0005 U/μl yeast inorganic pyrophosphatase and appro-
priately diluted enzyme. Assays were initiated by addition of Glc-1P in a
total volume of 50 μl. The reaction mixture was incubated for 10 min at
37 °C and terminated by adding the Malachite Green reagent. The com-
plex formedwith the released Pi wasmeasured at 630 nm in aMultiskan
Ascent microplate reader (Thermo Electron Corporation). The conver-
sion of substrates to the expected products was conﬁrmed using proton
NMR spectroscopy.
Alternatively, assay B was replaced by the radiometric coupled assay
method [48], measuring the synthesis of ADP-[14C]Glc from [14C]Glc-1P
andATP. The standard reactionmixture contained100mMMOPS buffer,
pH 8.0, 10 mM MgCl2, 1 mM [14C]Glc-1P (100–1000 cpm/nmol),
1.5 mM ATP, 0.5 U/ml inorganic pyrophosphatase, 0.2 mg/ml BSA and
enzyme in a total volume of 0.2 ml. Reaction mixtures were incubated
for 10 min at 37 °C and terminated by heating in a boiling-water bath
for 1 min. The ADP-[14C]Glc was then converted to [14C]glycogen by
the addition of E. coli GSase and non-radioactive glycogen as a primer.
Glycogen formed was precipitated and washed, and the radioactivity
measured in a scintillation counter.
Tre-6P Sase. Synthesis of Tre-6P from NDP-Glc and Glc-6P was
assayed bymeasuring NADH formation at 340 nmvia the coupled spec-
trophotometric method previously utilized for other glycosyl transfer-
ases [40,49,50]. The standard media contained 50 mM MOPS, pH 8.0,
5 mM MgCl2, 5 mM MnCl2, 0.3 mM phosphoenolpyruvate, 0.3 mM
NADH, 2.5 mM NDP-Glc, 5 mM Glc-6P, 2 U pyruvate kinase, 2 U lactate
dehydrogenase and 0.2 mg/ml BSA and appropriately diluted enzyme
in a ﬁnal volume of 100 μl. Reactions were incubated at 37 °C in a 96-
well microplate and oxidation of NADH was followed at 340 nm using
a Multiskan Ascent microplate reader (Thermo Electron Corporation).
The conversion of substrates to the expected products was conﬁrmed
using proton NMR spectroscopy.
GSase. The assaywas conducted as described in [51], using a solution
that contained 1 mM ADP-[14C]Glc (500–1500 cpm/nmol), 10 mM
MgCl2, 2.5 mg/ml rabbit liver glycogen, 50 mM bicine–NaOH, pH 8.0,
and 0.2 mg/ml BSA in a total volume of 100 μl. Assays were started by
adding 20 μl of GSase dissolved in 20 mM triethanolamine-HCl,
pH 8.0. GSase activity was alternatively measured with the same proce-
dure used for Tre-6P Sase, but replacing Glc-6P by 2.5 mg/ml rabbit
liver glycogen, according to [50]. The conversion of substrates to the
expected products was conﬁrmed using proton NMR spectroscopy.
One unit of activity (U) is deﬁned as the amount of enzyme catalyzing
the formation of 1 μmol of product per min under the conditions
described.
Fig. 1. Expression ofMtb H37Rv ADP-Glc PPase with the vector pMIP12 inM. smegmatis
mc2155. (A) Activity histogram of soluble samples. (B) Immunodetection of ADP-Glc
PPase of corresponding samples in A after SDS-PAGE and immunobloting. The lanes are
deﬁned as follows: pMIP12, crude extracts from M. smegmatismc2155 cells transformed
with pMIP12 (empty vector control); pMIP12/glgC, crude extracts from M. smegmatis
mc2155 cells transformed with pMIP12/MtbglgC; GlgC, puriﬁed ADP-Glc PPase; WB con-
trol, denatured/solubilized pellet from E. coli BL21cells transformed with pET19/MtglgC.
Samples were assayed for activity in the direction of ADP-Glc synthesis, as stated under
Materials and methods for Assay B.
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Saturation curves were deﬁned by assaying enzyme activity at
different concentrations of the variable substrate or effector with satu-
rating levels of the other components. The experimental datawere plot-
ted as enzyme activity (U/mg) versus substrate (or effector)
concentration (mM), and kinetic constants were determined by ﬁtting
the data to the Hill equation as described elsewhere [52]. Fitting was
performed with the Levenberg–Marquardt nonlinear least-squares al-
gorithm provided by the computer program Origin™. Hill plots were
used to calculate the Hill coefﬁcient (nH), the maximal velocity (Vmax),
and the kinetic constants that correspond to the activator or substrate
concentrations giving 50% of the maximal activation (A0.5), or velocity
(S0.5). All kinetic constants are the mean of at least three independent
sets of data, which were reproducible within ±10%.
3. Results
3.1. Molecular cloning of genes fromM. tuberculosis H37Rv and production
of soluble recombinant proteins
To gain knowledge on the properties of key enzymes involved in car-
bohydrates metabolism in mycobacteria, we designed experimental
strategies to recombinantly produce the proteins with high purity.
Using the information available from the genome project ofMtb (strain
H37Rv) [38], we ampliﬁed four genes deﬁning the metabolic node in-
volving Glc-1P and NDP-Glc from genomic DNA. The genes thus cloned
were glgC (1215 bp), glgA (1164 bp), galU (912 bp) and otsA (1503 pb),
respectively encoding ADP-Glc PPase, GSase, UDP-Glc PPase and Tre-6P
Sase. The otsA gene could be expressed in E. coli BL21 (DE3) using the
pRSETB/otsA construct to produce the mycobacterial Tre-6P Sase in a
soluble and active form, following the strategy previously reported for
this enzyme [40]. The expression was conducted using 0.1 mM IPTG
during 4 h at 23 °C, conditions under which most of the protein was
in the insoluble fraction, but reaching a level of soluble and active
enzyme sufﬁcient for its puriﬁcation.
It has been reported that many mycobacterial proteins are particu-
larly recalcitrant to heterologous expression in E. coli cells as soluble
forms [53,54]. This was our experience with the production of the
other three proteins (besides Tre-6P Sase) characterized in this study.
The genes glgA, glgC and galU could not be expressed in E. coli to give
soluble proteins using pRSETB or pET vectors, even when different
expression conditions were attempted, as detailed by Supplemental
Fig. 1 for production of ADP-Glc PPase. A high level of production of
the recombinant proteins was observed but only in the insoluble frac-
tion, even when temperature and time of expression were modiﬁed.
Similar results were obtained with different growth media or using
a strategy of co-expression with chaperones; conditions that usually
are effective to overcome the expression of insoluble proteins from
actinobacteria [27]. All expression conditions tested were unsuccessful
in obtaining signiﬁcant levels of ADP-Glc PPase in a soluble form that
could be detected using the activity assay or with speciﬁc antibodies
in western blots. Despite being able to produce a little soluble protein
through denaturation and refolded according to established protocols
[55–57], it was not possible to obtain any detectable activity.
To overcome problems associated with expression of mycobacterial
proteins in E. coli, we selected the alternative of using a more related
bacterium as a surrogate and a more compatible host. Thus, glgC, glgA
and galU genes from Mtb H37Rv were cloned into pMIP12 for expres-
sion in M. smegmatismc2155 cells. Using this procedure, recombinant
ADP-Glc PPase was produced as a soluble protein (Fig. 1) that could
be detected in western-blots and further puriﬁed. Also, the speciﬁc ac-
tivity of the enzyme in crude extractswas about one order ofmagnitude
higher than that detected in cells ofM. smegmatismc2155 transformed
with pMIP12 alone (empty vector control). This strategy was also
successful for the expression of UDP-Glc PPase and GSase.Either using the pMIP12 or the pRSETB vector system, the four
enzymes fromMtbwere produced as proteins having a fusedHis-tag re-
spectively at the C-terminus (ADP-Glc PPase, UDP-Glc PPase andGSase)
or the N-terminus (Tre-6P Sase). The use of the His-tag was convenient
in two ways. First, it enabled the separation of each recombinant
enzyme from its respective ortholog protein occurring in the host cell.
Secondly, it allowed the puriﬁcation in one-step by IMAC to give each
enzyme with a high degree of purity as determined by SDS-PAGE
(Supplemental Fig. 2). The values of speciﬁc activity of the puriﬁed
enzymes were 3.3 and 2.7 U/mg for ADP-Glc PPase and UDP-Glc
PPase, respectively (both determined in the direction of NDP-Glc
synthesis using Assay B), 0.2 U/mg for GSase and 1.6 U/mg for Tre-6P
Sase (in the direction of Tre-6P synthesis).
3.2. Kinetic properties of the recombinant mycobacterial enzymes
Table 1 summarizes the kinetic parameters determined for recombi-
nant ADP-Glc PPase, UDP-Glc PPase andGSase. The pyrophosphorylases
were characterized in both directions of catalysis (NDP-Glc synthesis
and pyrophosphorolysis) and using Mg2+ as an essential cofactor.Mtb
ADP-Glc PPase exhibited between 2- and 3-fold lower afﬁnity for ATP
and Glc-1P compared with those reported for the enzyme from the
related actinobacteria S. coelicolor [27] andM. smegmatis [58]. However,
it had a Vmax of ~3 U/mg, which is almost 20-fold higher than that
reported for the S. coelicolor enzyme [27]. TheMtb ADP-Glc PPase gave
saturation kinetics forMg2+, ATP, ADP-Glc andGlc-1Pwith different de-
grees of sigmoidicity. The behavior of PPi was unusual, since no satura-
tion could be achieved for the substrate in the concentration range
evaluated (up to 2mMPPi, where higher concentrations can precipitate
in the assay medium) and thus the afﬁnity parameter could only be
estimated (Table 1).
In the two directions of catalysis (UDP-Glc synthesis and pyro-
phosphorolysis), the UDP-Glc PPase fromMtb showed similar speciﬁc
activities (~2.5 and ~1.6 U/mg, respectively), with afﬁnities for the
Table 1
Kinetic parameters for ADP-Glc PPase, UDP-Glc PPase and GSase from Mtb. Values
represent means of three independent experiments.
Enzyme Substrate S0.5 (mM) nH Vmax (U/mg)
ADP-Glc PPase
Assay A ATP 1.20 ± 0.08 2.2 3.32 ± 0.11
Glc-1P 1.07 ± 0.09 1.4
Mg2+ 1.29 ± 0.13 2.3
Assay B ADP-Glc 0.76 ± 0.09 2.1 1.41 ± 0.08
PPi N2 –
Mg2+ 0.81 ± 0.09 3.0
UDP-Glc PPase
Assay A UTP 0.10 ± 0.02 1.2 2.52 ± 0.09
Glc-1P 0.13 ± 0.01 1.5
Mg2+ 0.46 ± 0.07 2.9
Assay B UDP-Glc 0.76 ± 0.04 1.0 1.63 ± 0.11
PPi 0.61 ± 0.05 1.6
Mg2+ 0.47 ± 0.06 3.6
GSase
ADP-Glc 3.95 ± 0.12 2.5 0.21 ± 0.02
Glycogen 0.30 ± 0.02 (mg/ml) 2.1
Table 2
Kinetic parameters for Tre-6P Sase fromMtb.
Substrate S0.5 (mM) nH Vmax (U/mg)
ADP-Glc 0.14 ± 0.01 1.3 1.37 ± 0.11
Glc-6P 1.43 ± 0.08 1.0 1.84 ± 0.08
UDP-Glc 1.54 ± 0.07 1.4 1.19 ± 0.10
Glc-6P 6.21 ± 0.12 0.9 1.28 ± 0.09
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ly, results indicate that theMtb enzyme reported herein is 25-fold more
active for UDP-Glc synthesis than the same enzyme characterized after
its recombinant expression using E. coli as a host [59], consistent with
expression in the Gram-negative host being problematic. In the this di-
rection of catalysis, the Vmax determined forMtb UDP-Glc PPase is two
orders of magnitude lower that that reported for the homologous en-
zyme from S. coelicolor [27]. However, the afﬁnity for its substrates is
~10-fold higher than those of ADP-Glc PPase fromMtb and of UDP-Glc
PPase in crude extracts ofM. smegmatis [58] (Table 1). Concerning the
Mtb GSase, its kinetic parameters shown in Table 1 are similar to those
reported for the enzyme from the related Gram-positive bacterium
S. coelicolor [27], except for a 30-fold lower afﬁnity for ADP-Glc exhibit-
ed by the former.
Both pyrophosphorylases and the GSase fromMtbwere highly spe-
ciﬁc for the nucleotide substrates. Thus, GSase used ADP-Glc to elongate
glycogen and no activity was detected with UDP-Glc up to 10 mM. Fur-
thermore, UDP-Glc was not an inhibitor of the reaction with ADP-Glc.
The analysis of different NTPs (ATP, UTP, GTP, dTTP) as substrates of
ADP-Glc PPase and UDP-Glc PPase (assayed up to 5 mM) showed com-
plete speciﬁcity for the use of ATP and UTP, respectively. These results
are consistent with the functional operation of the pathways for glyco-
gen biosynthesis (via ADP-Glc, the GlgCA route) or the metabolism of
structural oligo and polysaccharides as well as sugar inter-conversion
(by using UDP-Glc) in bacteria [11,12].
The recombinant Mtb Tre-6P Sase was found to use both, UDP-Glc
and ADP-Glc as substrates for synthesis of Tre-6P (Fig. 2). Although
the enzyme reached similar Vmax values with UDP-Glc and ADP-GlcFig. 2. Saturation plots ofMtb Tre-6P Sasewith the substratesNDP-Glc (A) andGlc-6P (B). The ef
the presence of 1.5 mM Glc-6P and that of Glc-6P in the presence of 1 mM ADP-Glc or 5 mM U(52% higher with the latter), major differences arise when S0.5 values
are compared (Table 2 and Fig. 2A). Thus, the afﬁnity of the enzyme
toward ADP-Glc was found to be one order of magnitude higher than
for UDP-Glc. In addition, when the activity was assayed in the presence
of saturated concentration of ADP-Glc, Tre-6P Sase exhibited 4.3-fold
lower S0.5 for Glc-6P compared with activity using UDP-Glc (Table 2
and Fig. 2B). Saturation plots for Glc-6P with either NDP-Glc were
hyperbolic, while both ADP-Glc and UDP-Glc gave slight positive
cooperativity. We also tested Tre-6P activity with Fru-6P, Fru-1,6-bisP,
mannose-6P or sorbitol-6P instead of Glc-6P in the presence of APG-
Glc or UDP-Glc. The mycobacterial enzyme was strictly speciﬁc for
Glc-6P in accordance with previous work [40,60]. Nevertheless, this is
the ﬁrst kinetic analysis of theMtb Tre-6P Sase showing the preferential
use of ADP-Glc as the main donor substrate.
3.3. Regulatory properties of the recombinant mycobacterial enzymes
ADP-Glc PPases fromdifferent sources are allosterically regulated by
key metabolites belonging to the principal carbon assimilation route in
the respective organism [11,25]. It has been established in many bacte-
ria that regulation of the enzyme is critical to determine the track of
Glc-1P in cellular carbon metabolism [11]. To assess the issue in Mtb,
we explored the potential regulatory properties of the recombinant
enzymes in this study. Activation-inhibition assays were performed
for the Mtb ADP-Glc PPase with compounds that are known to be
important effectors of the enzyme in various organisms [11,25,27]:
pyruvate, phosphoenolpyruvate (PEP), 3-phosphoglycerate, Fru-6P,
Fru-1,6-bisP, ribose-5P, Glc-6P, mannose-1P, mannose-6P, AMP, ADP,
Pi, NAD(P)+, and NAD(P)H. The concentration of the effectors analyzed
ranged between 0.05 and 5 mM while substrates were maintained at
saturating concentrations. PEP and Glc-6P were activators ofMtb ADP-
Glc PPase giving up to a 3-fold increase in activity. Also, a very weak
activation was observed with Fru-6P (1.3-fold at 5 mM). On the other
hand, AMP and ADP showed slight inhibitory effects, diminishing the
activity up to 50%; while Pi, a common inhibitor for ADP-Glc PPases
(e.g. the enzyme from S. coelicolor), had no effect on the Mtb enzyme.
It is worth mentioning that both PEP and Glc-6P were reported as
activators of the ADP-Glc PPase from M. smegmatis [58] and
S. coelicolor [27], thus suggesting a common activation in these phyloge-
netically related actinobacteria. Conversely, Mtb UDP-Glc PPase andfect of ADP-Glc (empty circles) andUDP-Glc (ﬁlled circles) concentrationswere assessed in
DP-Glc.
Fig. 3. Saturation plots for the allosteric activation of ADP-Glc PPase fromMtb. Curveswere
made in the ADP-Glc synthesis direction of catalysis with Assay A in the presence of 2mM
PEP (empty circles) or 2 mM Glc-6P (ﬁlled circles).
Fig. 4. Saturation plots for the activation of Mtb Tre-6P Sase by Fru-6P. Curves were
obtained with 10 mM Glc-6P and either 2 mM ADP-Glc (empty circles) or 10 mM UDP-Glc
(ﬁlled circles).
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lack of regulatory properties already reported for both enzymes from
prokaryotes [21,23,24,27,44,61], including that fromM. smegmatis [58].
Characterization of the response ofMtb ADP-Glc PPase to effectors
is particularly important for a deeper comprehension of carbon
partitioning at the metabolic Glc-1P node as well as a better under-
standing of glycogen synthesis by the mycobacterial classical GlgCA
pathway. Saturation kinetics for Glc-6P and PEP indicated that the effec-
tors enhanced the activity of theMtb enzyme by 2.4- and 2.9-fold, with
A0.5 values of 0.87 and 0.09 mM, respectively (Fig. 3). However, the
effect of both compounds was not only exerted on the enzyme Vmax,
but they also decreased values of S0.5 for substrates. Results in Table 3
highlight the importance of Glc-6P in the activation of themycobacterial
ADP-Glc PPase, since the effector increased by ~5-fold the enzyme's
apparent afﬁnity for Glc-1P and ATP, with a consequent enhancement
of the kcat/S0.5 ratio (equivalent to kcat/Km or catalytic efﬁciency for
hyperbolic kinetics) by one order ofmagnitude. The effect of PEPmainly
enhanced the enzyme's afﬁnity for ATP and increased by ~7-fold the
catalytic efﬁciency with this substrate (Table 3). These results suggest
that the reaction catalyzed by ADP-Glc PPase would be under allosteric
regulation by keymetabolites of the carbonmetabolism inMtb, which is
a characteristic common to other bacteria [11,12,25]. Concerning the
regulatory properties of the mycobacterial enzyme, they resemble
those reported for S. coelicolor ADP-Glc PPase, which also has Glc-6P
and PEP as its main activators [27].Table 3
Analysis of the activation of ADP-Glc PPase fromMtb.
Condition Substrate
ATP Glc-1P
Relative afﬁnity a
No effector 1.0 1.0
2 mM Glc-6P 5.2 4.6
2 mM PEP 2.3 1.2
Relative activity b
No effector 1.0 1.0
2 mM Glc-6P 2.5 2.4
2 mM PEP 2.9 3.0
Relative catalytic efﬁciency c
No effector 1.0 1.0
2 mM Glc-6P 13 11
2 mM PEP 6.7 3.6
a Calculated as the ratio of S0.5 values obtained in absence over in presence of the
effector.
b Calculated as the ratio of Vmax values obtained in presence over in absence of the
effector.
c Calculated as the ratio between (kcat/S0.5) values obtained in presence over in absence
of the effector.The recombinant Mtb Tre-6P Sase was also analyzed for allosteric
regulation by metabolites. Only Fru-6P had an effect, activating the en-
zyme by 2-fold when assayed either with ADP-Glc (2 mM) or UDP-Glc
(10 mM). Saturation kinetics shown in Fig. 4 indicate that the enzyme
exhibited a higher apparent afﬁnity for the activator when the substrate
was ADP-Glc comparedwith UDP-Glc, with A0.5 values for Fru-6P deter-
mined to be 0.33 and 1.1 mM, respectively. The activating effect was
mainly on Vmax, as the values of S0.5 for the enzyme substrates were
not signiﬁcantly modiﬁed when determined in the presence of Fru-6P
(data not shown). Previous reports on the regulation of mycobacterial
Tre-6P Sase only referred the activation by polyanions acting at relative-
ly high concentrations [60,62]. This effect was analyzed in detail for the
Mtb enzyme by Pan and collegues [40], describing that both the recom-
binant Tre-6P Sase and the onepuriﬁed from crude extracts have similar
properties in the presence or absence of polyanions. In addition, recent
work characterizing both Tre-6P Sase isoforms from R. opacus showed
that one of them is strongly dependent on heparin activation (OtsA2),
but not the other (OtsA1) [63]. We have focused on regulation by
metabolic intermediates and, although modest, the activation of the
enzyme by the glycolytic intermediate Fru-6P as described in the
present study could have a physiological role in mycobacteria.
4. Discussion
Regulation of glycogen synthesis has been extensively analyzed in
Gram-negative bacteria (mainly in E. coli) [11,12], but markedly scarce
information is available concerning other prokaryotes. Recently, the
occurrence of the polysaccharide in mycobacteria and actinobacteria
acquired additional interest, because a novel GlgE pathway relating
Tre and glycogen metabolism was discovered with implications in the
development of new drugs against TB [28,32,33,64]. It was recently
demonstrated that in Mtb the maltosyltransferase GlgE is negatively
regulated by phosphorylation of Ser/Thr residues [33]. However, the ki-
netic and regulatory characterization of the NDP-Glc-related enzymes
in the classical GlgCA pathway for glycogen synthesis and for Tre
biosynthesis in Mtb have not been performed. This is critical for an
understanding of the relationships between pathways leading to the
synthesis of oligo and polysaccharides that serve as structural compo-
nents, carbon reserves and bioactive compounds in the pathogen. All
of the Glc polymer pathways relevant to this work form a complex net-
work [28]. For example, the GlgE and GlgCA pathways have potentially
common intermediates (e.g. maltooligosaccharides) and Tre can be
regenerated from glycogen via the TreXYZ pathway. Nevertheless, all
of these polysaccharides and Tre must ﬁrst be synthesized via either
ADP-Glc or UDP-Glc from Glc-1P.
In the present work we report the molecular cloning, recombinant
expression and characterization of four enzymes that deﬁne the parti-
tion of Glc-1P into different anabolic routes of carbohydrates in Mtb.
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gene in E. coli, which was of utility to deﬁne properties of the enzyme
that were not identiﬁed in previous studies [40,60] and that are of
value for a better understanding of the metabolism of the disaccharide.
In addition, ADP-Glc PPase and GSase (mainly involved in glycogen syn-
thesis) as well as UDP-Glc PPase were recombinantly produced with
high purity after expression in M. smegmatis mc2155. This strategy
was critical to solve a recalcitrant problem for the soluble expression
of these enzymes in E. coli, which has been reported formany othermy-
cobacterial proteins [53,54,65,66].
The kinetic and regulatory properties of the enzymes herein charac-
terized are shown in Fig. 5 within the metabolic context ofMtb, where
the pathways determining the fate of Glc-1P into oligo and polysaccha-
rides, Tre, and glycogen are interlinked. The speciﬁcity determined
for UDP-Glc PPase, ADP-Glc PPase and GSase support the occurrence
of the classical ADP-Glc-dependent GlgCApathway for glycogen synthe-
sis, where ADP-Glc PPase is regulated by Glc-6P and PEP, two key
metabolites of glycolysis. Thus, Glc-1P would be utilized to produce
either UDP-Glc in a constant non-regulated manner or ADP-Glc in a
regulated manner when levels of the glycolytic intermediates are in-
creased. It is noteworthy that our results suggest that ADP-Glc would
serve not only for glycogen synthesis but also to produce Tre-6P
(Fig. 5). The importance of the sugar nucleotide for the accumulation
of the polysaccharide agrees with previous works [13] demonstrating
that a glgC knockout mutant of Mtb H37Rv accumulated 40–50% less
glycogen and capsular glucan comparedwith thewild type strain. How-
ever, the promiscuitywe determined for Tre-6P Sase to useADP-Glc and
to some extent UDP-Glc is a novel characteristic that necessitates a
revised view of the essential OtsAB pathway in Mtb [67]. This new
view also reinforces the critical metabolic node constituted by Glc-1P
in the microorganism, as it is a key intermediate in the interconnection
between Tre and glycogenmetabolisms [28,30,32,33,64], as well as also
being a key precursor for the synthesis of mycolic acids derivatives [68,
69]. Thus it seems likely that the constitutive production of UDP-Glc
would serve the biosynthesis of MGLPs and Tre, which in turn feeds
into glucan and cord factor biosynthesis.When the glycolytic intermedi-
ates PEP and Glc-6P build up, ADP-Glc production increases, which not
only diverts ﬂux into the GlgCA glycogen pathway but also increases
ﬂux into Tre production. The latter is also enhanced by the activation
of Tre-6P Sase by Fru-6P.
The regulatory properties of theMtb ADP-Glc PPase are distinct from
those of other prokaryotes [11], but similar to the homologous protein
from the related Gram-positive bacteria M. smegmatis [58] andFig. 5. The metabolic pathways ofMtb that interconnect glycogen, Tre and other carbohydrate
MGLP. The enzymes characterized in this work (ADP-Glc PPase, UDP-Glc PPase, GSase and T
ADP-Glc PPase and Tre-6P Sase. The wide-dashed arrow symbolizes the gluconeogenesis pathwS. coelicolor [27]. Despite some differences in the sensitivity to activation
by Glc-6P and PEP, the fact that both ADP-Glc PPases from actinobacteria
mainly respond to these effectors suggests the occurrence of similar do-
mains involved in allosteric regulation given their close phylogenetic re-
latedness. The speciﬁcity toward effectors exhibited by the enzyme has
commonalities with characteristics reported for the occurrence and
modulation of other metabolic routes in mycobacteria. For example,
M. smegmatis pyruvate kinase (catalyzing the conversion of PEP into
pyruvate plus ATP) is activated by Glc-6P [70], and the hexose-P was
reported as a key essential intermediate for mycobacterial metabolism
[71].
It has been proposed that carbohydrates inMtb may be utilized for
anabolic rather than catabolic purposes during host infection [6]. This
was based on observations that the organism: (i) lacks PEP carboxylase,
which is functionally replaced by pyruvate carboxylase, and (ii) several
key glycolytic enzymes (triose-P isomerase, phosphoglycerate kinase
and glyceraldehyde-3-P dehydrogenase) are dispensable for growth
on a source of carbohydrates [5,72,73]. In addition, recent studies on a
(neo)glycolytic pathway found inMtb have attracted much interest by
shedding light on the importance that central metabolism has in the
bacterium's biology, with new features (e.g. co-metabolism, re-routing
or plasticity) being described [4,6–9,74]. Thus, fatty acids seem to be
actively catabolized to provide carbon and energy in mycobacteria,
whereas carbohydrates are scavenged to provide biosynthetic precur-
sors such as Glc-6P [3,4,6,8,72]. These metabolic peculiarities enhance
the importance of Glc-6P and PEP [themetabolites located at the begin-
ning/end of the (neo)glycolytic and gluconeogenic pathway (see Fig. 5)]
as main allosteric activators of ADP-Glc PPase, since the classical GlgCA
pathway for glycogen synthesis would be fully operative when levels of
carbohydrates are being maintained high via anaplerosis.
It has been recently demonstrated thatMtb requires phosphorylated
Glc to supportmouse infection, suggesting the essentiality of the hexose
for the bacterium's metabolism [74]. On the other hand, a mutant lack-
ing phosphofructokinase activity showed that accumulation of Glc-6P
and/or Fru-6P was detrimental for Mtb growing in anaerobic condi-
tions [9], which is consistent with the toxicity of other sugar-P [64] or
metabolic intermediates [75]. Taking into account these and our results,
it could be speculated that there is another role for glycogen inMtb. The
polysaccharide could function as a carbon-buffer/capacitor, since an
increment in the hexose-P pool could be directed to the polyglucan
via the classical GlgCA pathway. It is noteworthy that in the close
relative organism Corynebacterium glutamicum, glycogen was proposed
as a carbon capacitor [76,77].s. The scheme includes links between pathways for glycogen, Tre (wide gray arrows) and
re-6P Sase) are shown in blue boxes. The green lines indicate the allosteric activation of
ay and→→ indicates several enzymatic steps.
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charide (MGLP) are polymers playing critical roles for Mtb physiology
[13]. Pathogenic mycobacteria are surrounded by a non-covalently
bound capsule, whose major carbohydrate constituent is a glycogen
like α-glucan. This cover plays a key role during the ﬁrst stages of infec-
tion. Glycogen and α-glucan may even share in part a common biosyn-
thetic route [14,78,79]. Additionally, glucosyl-3-phosphoglycerate
synthase (GpgS) from Mycobacterium bovis BCG catalyzes
glucosylglycerate synthesis by condensation of NDP-Glc and 3-phospho-
glycerate [17,80]. This molecule is the precursor for the biosynthesis of
MGLP participating in modulation of fatty acids elongation [15–17].
GpgS utilizes both UDP-Glc and ADP-Glc, having a similar Vmax, although
with a 6-fold higher afﬁnity toward the former sugar nucleotide [17]. The
MGLP molecule is predicted to be elongated by the glycosyltransferase
Rv3032 which also utilizes NDP-Glc, but the substrate speciﬁcity has
yet to be reported in detail. Thus, the glucosyl transferase activity re-
quired for the glucan backbone of these three macromolecules (glyco-
gen, α-glucan and MGLP) [13,15] would be originally supplied with
glucose building blocks coming from ADP-Glc PPase and/or UDP-Glc
PPase characterized in this work. UDP-Glc PPase afﬁnity for Glc-1P is
10-fold higher than ADP-Glc PPase afﬁnity for same substrate (in ab-
sence of allosteric effector). In this context, Glc-1P would be constantly
used to synthesize UDP-Glc, while its ﬂuctuating consumption by ADP-
Glc PPasewould bemainlymodulated toward the enzyme allosteric reg-
ulation by levels of Glc-6P and PEP (Fig. 5).
Mtbhas becomea formidable pathogen by utilizingwhatever carbon
it can acquire to maximize its potential for growth. In order to achieve
this, it must carefully regulate metabolic ﬂuxes to key molecules
involved in carbon storage (cytosolic glycogen), immune evasion
(capsular alpha-glucan), the modulation of fatty acid biosynthesis
(MGLP) and pathogenesis (Tre mycolates). Each of these molecules is
originally generated via either ADP-Glc or UDP-Glc that are both gener-
ated fromGlc-1P.We have shown how this critical node is controlled by
the allosteric regulation of ADP-Glc PPase. More work is required to
identify other regulatory nodes that no doubt exist.
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